In this work, we utilize three human tumor cell lines and two independent approaches to characterize the in vitro implication of DDR1 in tumor malignancy through the analysis of tumor responses to collagen I. The first approach utilized a highly selective pharmacological inhibitor for DDR1-dependent signal transduction. Here, DDR1 is linked to neoplasm.